Stelara cleared for pediatric Crohn’s disease

What this means

Stelara is an injectable antibody drug that blocks two immune system proteins, IL-12 and IL-23, which play a role in inflammation. Today FDA approved Stelara for children as young as two years old with moderate to severe Crohn’s disease. This decision gives younger patients access to a treatment option that was previously only available for adults and older teens.